Putnam Investments’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-51,120
Closed -$347K 1242
2022
Q1
$347K Sell
51,120
-3,747
-7% -$25.4K ﹤0.01% 1105
2021
Q4
$458K Buy
+54,867
New +$458K ﹤0.01% 1049